These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17701528)

  • 21. Comparison of the steady-state pharmacokinetics, metabolism, and variability of a transdermal testosterone patch versus a transdermal testosterone gel in hypogonadal men.
    Mazer N; Bell D; Wu J; Fischer J; Cosgrove M; Eilers B;
    J Sex Med; 2005 Mar; 2(2):213-26. PubMed ID: 16422889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Permeability and retention studies of (-)epicatechin gel formulations in human cadaver skin.
    Suppasrivasuseth J; Bellantone RA; Plakogiannis FM; Stagni G
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1007-17. PubMed ID: 17012113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal Delivery of Cimetidine Across Microneedle-Treated Skin: Effect of Extent of Drug Ionization on the Permeation.
    Song Y; Herwadkar A; Patel MG; Banga AK
    J Pharm Sci; 2017 May; 106(5):1285-1292. PubMed ID: 28161442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal testosterone delivery: comparison between scrotal and nonscrotal delivery systems.
    Lin S; Xing QF; Chien YW
    Pharm Dev Technol; 1999 Aug; 4(3):405-14. PubMed ID: 10434286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation of a reservoir-type testosterone transdermal delivery system.
    Kim MK; Zhao H; Lee CH; Kim DD
    Int J Pharm; 2001 May; 219(1-2):51-9. PubMed ID: 11337165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Control Release; 2006 Jun; 113(1):57-62. PubMed ID: 16677734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel.
    Marbury T; Hamill E; Bachand R; Sebree T; Smith T
    Biopharm Drug Dispos; 2003 Apr; 24(3):115-20. PubMed ID: 12673669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of tretinoin gels for enhanced transdermal delivery.
    Shin SC; Kim HJ; Oh IJ; Cho CW; Yang KH
    Eur J Pharm Biopharm; 2005 May; 60(1):67-71. PubMed ID: 15848058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of carvone on the permeation of nimodipine from a membrane-moderated transdermal therapeutic system.
    Krishnaiah YS; Bhaskar P; Satyanarayana V
    Pharmazie; 2003 Aug; 58(8):559-63. PubMed ID: 12967033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of skin washing on systemic absorption of testosterone in hypogonadal males after administration of 1.62% testosterone gel.
    Stahlman J; Britto M; Fitzpatrick S; McWhirter C; Testino SA; Brennan JJ; Zumbrunnen TL
    Curr Med Res Opin; 2012 Feb; 28(2):271-9. PubMed ID: 22185431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo skin permeation and penetration of nonivamide from and in vivo skin tolerability of film-forming formulations containing porous silica.
    Heck R; Lukić MŽ; Savić SD; Daniels R; Lunter DJ
    Eur J Pharm Sci; 2017 Aug; 106():34-40. PubMed ID: 28546105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers.
    Tas C; Ozkan Y; Okyar A; Savaser A
    Drug Deliv; 2007 Oct; 14(7):453-9. PubMed ID: 17994363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of penetration enhancers on in vitro permeability of meloxicam gels.
    Jantharaprapap R; Stagni G
    Int J Pharm; 2007 Oct; 343(1-2):26-33. PubMed ID: 17531412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the transdermal absorption of nimesulide from three commercially available gel formulations.
    Dayal P; Kanikkannan N; Singh A; Sing M
    Drug Dev Ind Pharm; 2002 Mar; 28(3):297-304. PubMed ID: 12026222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new 2% testosterone gel formulation: a comparison with currently available topical preparations.
    Arver S; Stief C; de la Rosette J; Jones TH; Neijber A; Carrara D
    Andrology; 2018 May; 6(3):396-407. PubMed ID: 29600542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Film drying and complexation effects in the simultaneous skin permeation of ketoprofen and propylene glycol from simple gel formulations.
    Bowen JL; Heard CM
    Int J Pharm; 2006 Jan; 307(2):251-7. PubMed ID: 16289881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new discriminative criterion for the development of Franz diffusion tests for transdermal pharmaceuticals.
    Baert B; Boonen J; Burvenich C; Roche N; Stillaert F; Blondeel P; Van Boxclaer J; De Spiegeleer B
    J Pharm Pharm Sci; 2010; 13(2):218-30. PubMed ID: 20816007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of isopropyl myristate, isopropyl alcohol and a combination of both in hydrocortisone permeation across the human stratum corneum.
    Brinkmann I; Müller-Goymann CC
    Skin Pharmacol Appl Skin Physiol; 2003; 16(6):393-404. PubMed ID: 14528064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
    Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
    J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations.
    El-Kattan AF; Asbill CS; Kim N; Michniak BB
    Drug Deliv; 2000; 7(3):147-53. PubMed ID: 10989915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.